William Dawson

Part of Wellington Management Group LLP, Wellington Trust Co., NA is a financial institution that provides investment services. The company is based in Boston, MA. The company's description emphasizes the risks associated with various asset classes and investment products.

Catalyst Bioscience, Inc. develops and markets catalytic biopharmaceutical products. Its technology consists of methods to identify proteases with tailor-made specificity or improved pharmacological properties. The company was founded by Charles Craik, Sandra Waugh Ruggles and Christopher Thanos in 2003 and is headquartered in South San Francisco, CA.

Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. GOCOVRI is indicated for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy. ADS-5102 is a treatment for walking impairment in patients with multiple sclerosis. ADS-401 treats partial onset seizures in patients with epilepsy. Namzaric is a drug treatment for moderate to severe Alzheimer's disease. The company was founded by Gregory T. Went on November 15, 2000 and is headquartered in Emeryville, CA.

Nalu Medical, Inc. is a medical technology company, which develops, manufactures, and commercializes invasive solutions for patients with chronic neuropathic pain. It markets Nalu neurostimulation system that delivers gentle electrical pulses to the nervous system to modulate pain signals to the brain. The company was founded by Keegan Harper, Lee Hartley, Mike Partsch, and Daniel Pivonka in October 28, 2014 and is headquartered in Carlsbad, CA.